Yu-Hai Wang

Yu-Hai Wang

Auto-generated profile, based on publicly available information

Yu-Hai Wang

Department of Neurosurgery, 904th Hospital of Joint Logistic Support Force of PLA, Wuxi Clinical College of Anhui Medical University, Wuxi 214044, China

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 December 2024 in Neural Regeneration Research
Verified
Journal Article
Open access
MLMei Liu
Mei Liu
YMYijing Meng
Yijing Meng
SOSiguang Ouyang
Siguang Ouyang
MZMeng’AI Zhai
Meng’AI Zhai
LYLi kun Yang
Li kun Yang
YWYuhai Wang
Yuhai Wang
Spontaneous recovery frequently proves maladaptive or insufficient because the plasticity of the injured adult mammalian central nervous system is limited. This limited plasticity serves as a primary barrier to functional recovery after brain injury. Neuromodulation technologies represent one of the fastest-growing fields in medicine. These techniques utilize electricity, magnetism, sound, and light to restore or optimize brain functions by promoting reorganization or long-term changes that support functional recovery in patients with brain injury. Therefore, this review aims to provide a comprehensive overview of the effects and underlying mechanisms of neuromodulation technologies in supporting motor function recovery after brain injury. Many of these technologies are widely used in clinical practice and show significant improvements in motor function across various types of brain injury. However, studies report negative findings, potentially due to variations in stimulation protocols, differences in observation periods, and the severity of functional impairments among participants across different clinical trials. Additionally, we observed that different neuromodulation techniques share remarkably similar mechanisms, including promoting neuroplasticity, enhancing neurotrophic factor release, improving cerebral blood flow, suppressing neuroinflammation, and providing neuroprotection. Finally, considering the advantages and disadvantages of various neuromodulation techniques, we propose that future development should focus on closed-loop neural circuit stimulation, personalized treatment, interdisciplinary collaboration, and precision stimulation.

1 January 2016 in Asia Pacific Journal of Clinical Trials: Nervous System Diseases
Verified
Journal Article
Closed access
PDF file
YWYu-Hai Wang
Yu-Hai Wang
WLWei Lin
Wei Lin
SCSang Cai
Sang Cai
JZJie Zhu
Jie Zhu
YFYi Feng
Yi Feng
JCJun-Hui Chen
Jun-Hui Chen
Background: Traumatic brain injury is a high-incidence condition that can cause severe cognitive impairment. At present, functional magnetic resonance imaging is used to analyze changes in brain function and network connectivity at different stages of injury. In addition, tau protein expression in nerve cells may reflect cognitive function. However, the combined use of functional magnetic resonance imaging and tau measurement to assess cognitive function following traumatic brain injury has not yet been investigated. Methods/Design: A prospective inception cohort study will be performed at the 101 st Hospital of PLA, Wuxi, China. We will conduct a follow-up visit in 100 patients with traumatic brain injury. Cognitive function will be assessed within 24 hours of injury and 0.5, 1, and 2 years after injury. Primary outcomes will be the Montreal Cognitive Assessment score, functional magnetic resonance imaging results, and tau protein level in the cerebrospinal fluid. Secondary outcomes will include Mini-Mental State Examination Scale and Hamilton Depression Scale scores. We will assess cognitive function in patients with traumatic brain injury and analyze its correlation with functional imaging indexes and tau levels in the cerebrospinal fluid. Discussion: This trial has been designed to determine whether functional imaging indexes and tau level in the cerebrospinal fluid can predict recovery of cognitive function in patients with traumatic brain injury. It will provide objective evidence for the clinical prevention and treatment of cognitive dysfunction following traumatic brain injury. Trial registration: This trial was registered at Chinese Clinical Trial Registry (registration number: ChiCTR-OOC-16008574) on 31 May 2016. Ethics: Approved by the Ethics Committee of the 101 st Hospital of PLA, China (approval number: L2016002), the study protocol will be performed in accordance with the guidelines of the Declaration of Helsinki, formulated by the World Medical Association. Informed consent: Written informed consent will be obtained from participants or their guardians.

1 February 2010
Verified
Journal Article
Closed access
JDJi-Rong Dong
Ji-Rong Dong
XCXue-Jian Cai
Xue-Jian Cai
BWBiao Wang
Biao Wang
YWYu-Hai Wang
Yu-Hai Wang
ZSZhong-Hua Shi
Zhong-Hua Shi
QXQin-Yi Xu
Qin-Yi Xu

7 March 2026 in Brain Research
Verified
Journal Article
Closed access
WDWanying Du
Wanying Du
JCJunhui Chen
Junhui Chen
GCGefei Cheng
Gefei Cheng
YYYang Yang
Yang Yang
YSYaqin Shi
Yaqin Shi
YWYuhai Wang
Yuhai Wang